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Background– Repolarization is impaired in patients with type 1 diabetes mellitus (T1DM), 
and repolarization disturbances are associated with an increased mortality. To study cardiac 
repolarization, we assessed T-wave morphology in patients with T1DM without known heart 
disease. 
Methods– 855 T1DM patients without known heart disease were matched 1:2 with 1710 
people from a background population. Rate-corrected T-wave morphology markers were 
obtained. Patients were stratified by albuminuria. Results are mean±standard deviation. 
Results– T-waves were flatter (0.398±0.059 vs. 0.382±0.062, p<0.001) and more asymmetric 
(0.082±0.068 vs. 0.071±0.084, p=0.001) in T1DM. Patients with albuminuria had an 
increased heart rate (normoalbuminuria: 71±13bpm, microalbuminuria: 75±12bpm, p<0.001, 
macroalbuminuria: 78±12bpm, p<0.001) and more asymmetric T-waves (normoalbuminuria: 
0.079±0.060, microalbuminuria: 0.094±0.085, p<0.01, macroalbuminuria: 0.101±0.080, 
p<0.01), but the QTc interval remained unchanged. 
Conclusions– T1DM is associated with changes in T-wave morphology. T-wave asymmetry 
but not QTc interval is associated with albuminuria in T1DM and may be used for 
stratification. 
 





















T-wave morphologic markers describe the shape of the T-wave of the surface 
electrocardiogram (ECG). Using T-wave morphology, more detailed information beyond QT 
prolongation can be obtained about cardiac repolarization.
1-4
 Specifically, blockage of the 
Kv11.1 channel (hERG) underlying the rapid delayed rectifier potassium current, can be 
detected using markers for the asymmetry, flatness, and presence of notches for T-waves.
5
 
Changes in T-wave morphology has been linked to mortality in type 2 diabetes
6




Cardiovascular disease is the leading comorbidity in type 1 diabetes mellitus (T1DM),
8
 and 
the risk of cardiovascular death in young individuals with T1DM has been found to be up to 
40-fold higher compared to the background population.
9
 A particular syndrome, termed the 
“dead in bed” syndrome, in which unexpected nocturnal death of young individuals with 
otherwise healthy T1DM subjects occurs, has gained interest, and disturbances in 
autonomous dysfunction and prolonged repolarization may play a role in the syndrome.
10
  
We have previously described ECG changes in T1DM patients without known heart disease 
and with normal ejection fraction, which includes an increased heart rate of about 10 bpm, a 
prolonged QRS duration, and a prolonged repolarization in the young patients with T1DM.
11
 
This study aims to investigate differences in T-wave morphology in type 1 diabetes patients 
without known heart disease, with normal ejection fraction, and with various degrees of 
albuminuria – as a proxy for disease progression - compared to matched subjects from the 




















The Thousand & 1 ECG Study is a cohort study of 855 patients with T1DM and without 
known heart disease.
11, 12
 The patients were included at Steno Diabetes Center Copenhagen 
from 2010 through 2012. The study was performed in accordance with the Second Helsinki 
Declaration and was approved by the Danish Data Protection Agency (00934-Geh-2010-003) 
and the regional ethics committee (H-3-2009-139).
12, 13
 
Exclusion criteria were known cardiac disease, electrical conduction abnormalities and 
ejection fraction <50%. Known cardiac disease was defined as registered heart failure, 
congenital heart disease, or coronary heart disease including stable angina, previous acute 
myocardial infarction, percutaneous coronary intervention, or coronary artery bypass. 
Electrical conduction abnormalities included atrial fibrillation, atrial flutter, and left bundle 
branch block, or the presence of a pacemaker or an implantable cardioverter defibrillator. 
As a diabetes-free background population, two matched subjects per case were drawn from 
the Danish General Suburban Population Study (GESUS)
14
 and included in the Thousand & 1 
ECG Study. The GESUS Study describes a population of individuals aged 20 years and up 
from the Naestved municipality 70 km south of Copenhagen between 2010 and 2013. The 
study was performed in accordance with the Declaration of Helsinki and was approved by the 
Danish Data Protection Agency and the regional ethics committee (SJ-113 and SJ-114). 
Males and females were drawn independently and matched on age to the T1DM population 
as described previously.
11
 In the GESUS cohort, subjects with diabetes mellitus were 
excluded, as well as subjects with known heart disease or electrical conduction abnormalities. 
Known heart disease included self-reported previous myocardial infarction, stable angina, 
ischemic heart disease, and pacemaker. Electrical conduction abnormalities disturbances 


















In both groups, resting 12-lead 10-second ECGs were recorded from the supine position after 
a few minutes of rest and stored digitally. The Marquette 12SL software (version 21, GE 
Healthcare, Milwaukee, WI, USA) was used for automatic measurements. 
Heart rate, QRS duration, QT interval, and morphology combination score (MCS) including 
the sub-components asymmetry, flatness, and the presence of notches were obtained as 
previously described.
15
 The corrected QT interval was reported using the cubic root 
correction of Fridericia (QTcF) and the square root correction of Bazett (QTcB). All other 
continuous variables were corrected linearly with RR interval and reported with a subscript c 
for an expected heart rate of 60 bpm. 
The MCS is based on measurements of flatness, asymmetry, and notching of the T-wave 
(figure 1).
15
 For all component measurements, the first principal component of the ST-T 
segment of the median beat is used. Flatness is calculated on the normalized T-wave similar 
to the way kurtosis of any distribution is calculated. Asymmetry is calculated as the average 
squared difference in slope on both sides of the top of the T-wave. Based on the first and the 
second derivatives of the T-wave, potential notches are identified. The depth of any notch in 
the T-wave gives rise to the third component of the score. 
Measurements 
In both populations, blood pressures were obtained after five minutes of rest in the supine 
position. The estimated Glomerular Filtration Rate (eGFR) was obtained for both groups 
using the CKD-EPI formula.
16
 Levels of glycated hemoglobin (HbA1c), plasma potassium, 
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months of the ECG for the T1DM group. Body mass index (BMI) was calculated as body 
weight per height squared as kg/m
2
. 
Albuminuria was measured in the T1DM group in morning spot urine samples using 
immunoassay. Patients were categorized as normoalbuminuric if their albumin/creatinine 
ratio was within 3.4 mg/mmol creatinine. For those with elevated levels (>3.4 mg/mmol), 24-
hour sterile urine collections were obtained. If two consecutive albumin measurements of 
three total measurements were between 30-300 mg/day the patient was categorized as 
microalbuminuric, and for the result of >300 mg albumin/day, the patient would be 
categorized as macroalbuminuric. 
Statistics 
The R statistical package (version 3.4.3) was used, and continuous and categorical variables 
were reported as mean ± SD (standard deviation) and % (n), respectively. For continuous 
variables, linear regression was used to test for differences in means. For categorical 
variables, a χ
2
 test was used, or Fisher’s exact test if one entry contained less than 5 
observations. 
In the multivariate regression, the effects of T1DM and albuminuria were adjusted for clinical 
confounders by the inclusion of sex, age, BMI, systolic blood pressure, and plasma levels of 
potassium and cholesterol in the models. The sensitivity analysis for T1DM vs. background 
population included additional information on smoking (categorical as ‘never’, ‘previous’, or 
‘current’) and alcohol consumption (categorical as ‘less than 7 units per week’, ‘7-21 units 
per week’, or ‘more than 21 units per week’, one unit of alcohol corresponding to 12 gram). 
The sensitivity analysis for albuminuria in the T1DM group included information on 
smoking, alcohol consumption, physical activity (categorical as ‘lightly active: less than 3 
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week’, or ‘very active: more than 7 hours of physical activity per week’), and usage of 
betablockers, angiotensin converting enzyme inhibitors or angiotensin II antagonists, 





The clinical characteristics of the T1DM population and their age- and gender matched 
controls are listed in table 1. The patients with T1DM had a lower BMI and blood pressure 
compared to the background population, and a lower P-cholesterol. More T1DM patients had 
impaired renal function and the patients with T1DM had higher levels of HbA1c and P-
potassium compared to the background population. 
With increasing degree of albuminuria in T1DM, T1DM duration, systolic blood pressure, 
and HbA1c, increased whereas eGFR decreased. P-potassium was higher in the 
microalbuminuric group compared to normoalbuminuria, the potassium level in the 
macroalbuminuric group was similar to that in the microalbuminuric group but did not reach 
statistically significant difference compared to the normoalbuminuric group (p=0.09). Age 
and BMI were higher in microalbuminuria compared to normoalbuminuria, diastolic blood 
pressure was increased in the macroalbuminuric group only. 
 
T-wave morphology was altered in T1DM (table 2). The T-waves were more asymmetric and 
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background population. As a consequence, the combined score of MCS was higher in T1DM 
compared to control. 
 
The T1DM patients were categorized by degree of albuminuria: 20% had microalbuminuria 
and 8% had macroalbuminuria (table 2). The value of the asymmetry marker of the T-wave 
increased significantly with increasing degree of albuminuria i.e. disease progression, but 
interestingly the QT interval did not. Heart rate was correlated with the degree of 
albuminuria, and patients with micro- and macroalbuminuria had an increased heart rate of 4 
bpm and 7 bpm, respectively, compared to patients with normoalbuminuria. The QRS 
duration decreased with increasing degree of albuminuria, although the shorter duration in the 
microalbuminuric group was only borderline significant without additional adjustment 
(p=0.06). 
 
When correcting these findings for clinical confounders, the results remained virtually the 
same for both T1DM vs. background population and in T1DM stratified by degree of 
albuminuria (table 3). For patients with micro- and macroalbuminuria, heart rate was 
increased by 4 and 5 bpm, respectively, and the asymmetry marker of the T-wave was 
increased by 23% and 42%, respectively. The decrease in rate-corrected QRS duration was 
statistically significant in both groups with a magnitude of 2 and 3 ms for micro- and 
macroalbuminuria, respectively. 
For T1DM compared to the background population, there was no difference in smoking 
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sensitivity analysis on the T1DM vs. background population, the inclusion of smoking status 
and alcohol consumption in the model did not change the results significantly.  
4.1 % of patients with T1DM were treated with betablockers, 42.3 % took angiotensin 
converting enzyme inhibitors or angiotensin II receptor blockers to lower blood pressure, 
26.1 % used medication containing acetylsalicylic acid, and 16.3 % took calcium channel 
blockers. The use of medication was more prevalent with increasing degree of albuminuria 
for all of these medications. A sensitivity analysis revealed that correcting for use of 
medication, physical activity, alcohol consumption, and smoking status in the multivariable 




In the present study, we compared differences in T-wave morphology between patients with 
T1DM without known heart disease and normal left ventricular function compared to age and 
sex matched controls from the background population without diabetes mellitus. T-wave 
morphology was changed in T1DM compared to the background population. With increasing 
degree of albuminuria in the T1DM population, QTcF remained unchanged, but T-wave 
morphology markers identified subtle repolarization changes.  
 
T-wave morphology 
The T-waves of the T1DM population were more asymmetric and flat compared to the 
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with T1DM have impaired hERG potassium channel function.
5
 Hyperglycemia is known to 
cause a reduction in hERG function,
17
 and it is possible that chronic hyperglycemia explains 
the increased asymmetry and flatness of the T-wave which was found in T1DM. In the rabbit, 
diabetes has been found to reduce IKr, an effect that was mediated by oxidative stress and 
reversible with insulin. On the other hand, in the dog, IKr function was unaffected eight weeks 




Although both MCS and QTcF were unchanged with albuminuria, we found a significant 
increase in the asymmetry marker of the T-wave. Both flatness and asymmetry detect hERG 
blockade, but only asymmetry was associated with albuminuria. It is possible that the 
asymmetry marker is more sensitive to subtle hERG changes that do not affect the flatness of 
the T-wave. Logically, asymmetry must be affected by ST segment deviations,
5
 but the 
inclusion of J-point amplitude in the model did not change the asymmetry findings 
significantly. Similarly, HbA1c, eGFR, and diabetes duration did not explain the increase in 
asymmetry with albuminuria. In contrast, an increase in systolic blood pressure was 
associated with a decrease in T-wave asymmetry (results not shown). 
The QT interval was previously found to be related to albuminuria in patients with long term 
T1DM.
19
 In that study, however, the authors used the correction of Bazett (QTcB), which is 
known to have heavy residual heart rate dependence.
20
 As albuminuria is associated with 
elevated heart rate, the reported association probably reflects an increased heart rate rather 
than a prolongation of the QT interval. Indeed, we find that the macroalbuminuric group has 
a slightly longer QTcB compared to the normoalbuminuric group whereas QTcF is 
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Diabetic autonomic neuropathy is a known complication of T1DM that involves reduced 
heart rate variability and resting tachycardia.
21
 In the present study, the only marker for 
diabetic autonomic neuropathy was resting heart rate. All repolarization markers including 
T-wave morphology and QT interval have been appropriately corrected for heart rate. 
Diabetic autonomic neuropathy and nephropathy are correlated,
22
 and it seems likely that the 
association between albuminuria and repolarization arises because both neuropathy and 
nephropathy have chronic hyperglycemia as the underlying cause. 
The T1DM population in the present study were all without known heart disease and with 
ejection fraction >50%. Still, the T-wave morphology was significantly altered, suggesting 
impaired ionic current flow before the occurrence of clinical cardiac symptoms. The 12-lead 
ECG is an important tool for risk stratification and although the findings in this study suggest 
that asymmetry of the T-wave might be a predictor for the development of albuminuria in the 
T1DM population, intervention studies are needed to confirm the role of asymmetry in risk 
stratification. 
The finding that repolarization is impaired in patients with T1DM could support the theory, 
that impaired repolarization is a mechanism in the “dead in bed” syndrome. By the means of 
advanced T-wave analysis, one can obtain detailed information about cardiac repolarization, 
and it seems possible that T-wave analysis could become a tool for risk stratification in the 
clinic for patients with T1DM. However, further studies are needed to assess whether T-wave 
morphology markers such as MCS can predict the occurrence of the “dead in bed” syndrome. 
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For the T1DM population, we found that albuminuria was associated with an increase in 
heart rate. Others have found that albuminuria is associated with an elevated heart rate in the 
general population as well,
23
 and microalbuminuria increases the predictive power of ST-T 
wave abnormalities in the general population.
24
 
Compared to other studies, the T1DM group in the Thousand & 1 ECG Study seems to have 
a similar or lower prevalence of albuminuria relative to diabetes duration. In a previous 
Danish study with an average T1DM duration of 22 years, prevalences of 20% and 18% were 
found for microalbuminuria and macroalbuminuria, respectively.
25
 In the EDIC study, 16 % 
had microalbuminuria after an average T1DM duration of 14 years.
26
 In a Spanish study of 
asymptomatic patients with T1DM and without known coronary heart disease the mean 
diabetes duration was 20 years and microalbuminuria was found in only 9% of patients.
27
 
However, no patients above 50 were included in that study, which might in part explain the 
low prevalence. In the present study and the Spanish study, which both included patients with 
T1DM and without known heart disease, the inclusion criterion of no known heart disease 
likely represents a bias towards patients that are managing their diabetes better and therefore 
are less likely to develop albuminuria.  
 
Limitations 
Albuminuria was not assessed in the control group. Whereas plasma potassium was assessed 
and included in the full model, divalent cations such as calcium and magnesium were not. 
Although particularly calcium homeostasis may be disturbed in patients with diabetes, 
according to previous reports calcium affects primarily the duration of the ST segment but 
leaves the T-wave unaltered.
28
 The T-wave morphology variables are therefore likely to be 




















T-wave morphology, as a marker for repolarization disturbances, is altered in T1DM before 
the onset of clinical cardiac symptoms, possibly caused by a decrease in ventricular IKr 
function. Advanced T-wave morphology markers can provide additional information 
compared to the heart rate corrected QT interval, and asymmetry of the T-wave is associated 
with albuminuria in the T1DM population. 
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Table 1. Demographics for T1DM vs. background and in T1DM stratified by degree of 
albuminuria. 
Variable Background T1DM 
T1DM stratified by albuminuria 
Normo Micro Macro 
n 1710 855 619 170 66 
Age [years] (mean±SD) 49 ± 13 48 ± 15 46 ± 15 53 ± 14
†††
 48 ± 11 
T1DM duration [years] (mean±SD) - 25.0 ± 13.7 22 ± 13 31 ± 14
†††
 34 ± 11
†††
 
Sex [male] (% (n)) 51.7 (884) 51.7 (442) 52.2 (317) 53.5 (91) 51.5 (34) 
BMI [kg/m
2
] (mean±SD) 26.3 ± 4.4 25.6 ± 4.0
***
 25.4 ± 3.9 26.1 ± 4.2
†
 26.0 ± 4.5 
Systolic BP [mmHg] (mean±SD) 135.4 ± 19.3 133.1 ± 16.6
**
 131.3 ± 15.9 135.9 ± 16.3
††
 142.9 ± 19.1
†††
 
Systolic BP>140mmHg (% (n)) 36.4 (621) 28.0 (237)
 ***





Diastolic BP [mmgHg] (mean±SD) 84.0 ± 10.8 74.1 ± 9.7
***
 73.8 ± 9.3 73.7 ± 10.5 77.3 ± 10.6
††
 
Diastolic BP>90mmHg (% (n)) 24.1 (411) 4.7 (40)
 ***
 3.8 (23) 6.5 (11) 9.2 (6) 
eGFR [mL/min/1.73m
2
] (mean±SD) 91.0 ± 16.3 94.0 ± 21.0
***
 98.1 ± 16.9 88.3 ± 21.6
†††





 (% (n)) 3.6 (61) 7.1 (61)
 ***





HbA1c [%] (mean±SD) 5.4 ± 0.3 8.3 ± 1.3
***
 8.1 ± 1.3 8.4 ± 1.1
†
 9.0 ± 1.4
†††
 
HbA1c [mmol/mol] (mean±SD) 36 ± 3 67 ± 14
***
 65 ± 14 68 ± 12
†
 75 ± 16
†††
 
P-potassium [mM] (mean±SD) 3.87 ± 0.28 4.05 ± 0.34
***
 4.03 ± 0.31 4.10 ± 0.40
†
 4.11 ± 0.46 
P-cholesterol [mM] (mean±SD) 5.28 ± 0.99 4.84 ± 0.91
***
 4.86 ± 0.86 4.75 ± 0.85 4.92 ± 1.38 
**
p<0.01 vs. control; 
***
p<0.001 vs. control; 
†





p<0.001 vs. normoalbuminuria. BMI: Body Mass Index. BP: Blood 
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Table 2. ECG measurements. In albuminuria stratification, correction for age was applied 
due to age differences between the groups. 
Variable Background T1DM 
T1DM by albuminuria 
Normo Micro Macro 
n 1710 855 619 170 66 
Heart rate [bpm] (mean±SD) 63 ± 11 72 ± 13
***
 71 ± 13 75 ± 12
†††
 78 ± 12
†††
 
RR interval [ms] (mean±SD) 974 ± 166 854 ± 153
***
 870 ± 157 820 ± 133
†††
 794 ± 134
†††
 
QRSc duration [ms] (mean±SD) 95 ± 11 97 ± 11
**
 98 ± 10 96 ± 12 95 ± 9
†
 
QTcB [ms] (mean±SD) 415 ± 23 430 ± 22
***
 428 ± 22 431 ± 21 433 ± 21
†
 
QTcF [ms] (mean±SD) 412 ± 19 417 ± 17
***
 417 ± 16 416 ± 17 417 ± 19 
MCSc (mean±SD) 0.69 ± 0.19 0.72 ± 0.15
***
 0.72 ± 0.15 0.73 ± 0.20 0.73 ± 0.15 







Flatnessc (mean±SD) 0.383±0.063 0.399±0.057
***
 0.399±0.056 0.397±0.065 0.396±0.064 
Notch       
 None (% (n)) 99.4 (1700) 99.5 (851) 99.7 (617) 98.8 (168) 100 (66) 
 Subtle (% (n)) 0.1 (2) 0.2 (2) 0.2 (1) 0.6 (1) 0 (0) 
 Pronounced (% (n)) 0.5 (8) 0.2 (2) 0.2 (1) 0.6 (1) 0 (0) 
*
p<0.05 vs. control; 
**
p<0.01 vs. control; 
***





p<0.01 vs. normoalbuminuria; 
†††
p<0.001 vs. normoalbuminuria. MCS: 
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Table 3. T1DM and albuminuria effects on ECG measurements corrected for clinical 






T1DM by albuminuria 
Normo 
(mean±SD) 
Micro vs. normo 
(delta±SE) 
Macro vs. normo 
(delta±SE) 
n 1710 855 619 170 66 
Heart rate [bpm]  63 ± 11 10 ± 0.5
***
 71 ± 13 4 ± 1.1
†††
 6 ± 1.6
†††
 
RR interval [ms]  976 ± 166 -140 ± 7
***
 870 ± 157 -50 ± 13
†††
 -65 ± 20
†††
 
QRSc duration [ms]  95 ± 11 2.5 ± 0.4
***
 98 ± 10 -2.0 ± 0.9
†
 -2.8 ± 1.3
†
 
QTcB [ms]  415 ± 23 17 ± 0.9
***
 429 ± 22 2.6 ± 1.9 5.4 ± 2.8 
QTcF [ms]  412 ± 19 6 ± 0.8
***
 417 ± 16 -1.4 ± 1.5 0.0 ± 2.2 
MCSc  0.69 ± 0.18 0.04 ± 0.01
***








Flatnessc  0.382±0.062 0.020±0.003
***
 0.399±0.057 -0.001±0.005 0.002±0.008 
*
p<0.05 vs. control; 
***
p<0.001 vs. control; 
†





p<0.001 vs. normoalbuminuria. BMI: Body Mass Index. MCS: 
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Fig. 1. Morphology Combination Score (MCS). MCS is a composite of the three measures 
of asymmetry, flatness, and notching of the T-wave. The lower panel represents left: a 
visually normal T-wave with a low MCS; center: a visually normal T-wave, but MCS reveals 
that it is slightly abnormal; and right: a visually abnormal T-wave with a corresponding high 



























































 T-wave morphology is changed in patients with type 1 diabetes 
 Morphology changes precede known heart disease 
 T-wave asymmetry is associated with albuminuria in patients with type 1 diabetes 
 The QTc interval is not associated with albuminuria 
 Heart rate correlates with albuminuria  
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